Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneSTAT Molecular Diagnostics is a private U.S. molecular diagnostics company focused on developing and manufacturing diagnostic instruments, platforms, and assays, particularly for infectious disease testing. The company appears to operate from St. George, Utah and positions itself as an end-to-end provider of molecular diagnostic solutions. Publicly available descriptions emphasize faster, more accessible molecular testing for emerging diseases and specialized applications rather than a traditional therapeutic drug pipeline. Its activities are best characterized as in vitro diagnostics and molecular testing platform development rather than therapeutics. Available third-party sources indicate the business is active and commercially oriented, but detailed product-level pipeline disclosures are limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneSTAT Molecular Diagnostics.